Patient Controlled Injectors Market is expected to reach US$ 7,505.70 million by 2027

Mechanical Wearable Injectors Segment by Products to Grow at Faster Pace during Forecast Period

According to The Insight Partners market research study of “Patient Controlled Injectors Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, Application, Distribution Channel, and Geography”, the global patient controlled injectors market is expected to reach US$ 2,969.47 million by 2027 from US$ 7,505.70 million in 2019. The market is estimated to grow at a CAGR of 12.4% from 2020 to 2027. The report highlights trends prevailing in the global patient controlled injectors market and the factors driving market along with those that act as hindrances.

Based on product, the global patient controlled injectors market is segmented into electronic wearable injector, mechanical wearable injector, and infusion pumps. In 2019, the electronic wearable injectors segment held the largest share of the market; whereas, the mechanical wearable injectors segment is estimated to register the highest CAGR in the market during the forecast period. Factors such as rising adoption of mechanical injectors and emphasis on superior treatment outcomes are estimated to contribute to the mechanical wearable injectors segment growth.

The growth of the patient controlled injectors market is attributed to the factors such as increasing prevalence of chronic conditions and acceptance of patient controlled injectors due to better patient compliance. However, lack of awareness and adoption of patient controlled injectors in emerging countries is likely to restraint the growth of the market during the forecast period.

The demand for patient controlled injectors increased during the pandemic period. Factors such as increased patient population, shortage of healthcare resources, and ease of increased the adoption of injectors had positive impact on the market by certain extent. However, implementation of physical distancing policies and total shut down of businesses in order to prevent the viral infection disrupted the supply chain operations, which caused a negative impact on the market growth.  

Gerresheimer AG; F. Hoffmann-La Roche Ltd.; Johnson and Johnson Services, Inc.; Ypsomed AG; Westbourne Medical Limited; Enable Injections; scPharmaceuticals Inc.; United Therapeutics Corporation; and BD are among the leading companies operating in the patient controlled injectors market.  

Global Patient Controlled Injectors Market, By Regions, 2019 (%)

---

Patient Controlled Injectors Market Growth Report | 2021 to 2031

Download Free Sample

---

Patient Controlled Injectors Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Electronic Wearable Injectors, Mechanical Wearable Injectors, and Infusion Pumps), Application (Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Mail Order Pharmacies), and Geography

The report segments Global Patient Controlled Injectors Market as follows:

By Product

• Electronic Wearable Injector
• Mechanical Wearable Injector
• Infusion Pumps

By Application

• Cancer Treatment
• Auto-immune Treatment
• Blood Disorders Treatment
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Mail Order Pharmacies

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East & Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa
• South & Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of South & Central America